StockData
Medifast Inc logo

Medifast Inc (MED) shareholders

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
73.9%
8M of 11M shares
Institutional holders
113
26 new, 24 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
14 buys · 2 sales
Net bought $1.52M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Renaissance Technologies LLC
Joint filing with Renaissance Technologies Holdings Corporation (9.20%)
1,006,2109.20%13G (passive) amendmentSep 30, 2024
Parsa Kiai
Joint filing with Steamboat Capital Partners, LLC (7.10%)
790,6937.10%13D (active) amendmentAug 20, 2026
Renaissance Technologies Holdings Corporation
Joint filing with Renaissance Technologies LLC (6.96%)
773,7106.96%13G (passive) amendmentJan 2, 2026
Citadel Securities Group LP
Joint filing with Citadel Securities GP LLC (6.50%), Kenneth Griffin (6.50%) and 1 more
715,9106.50%13G (passive)Mar 31, 2026
Susquehanna Fundamental Investments, LLC
Joint filing with G1 Execution Services, LLC (6.00%), Susquehanna Securities, LLC (6.00%)
654,9456.00%13G (passive) amendmentSep 30, 2025
Susquehanna Portfolio Strategies, LLC
Joint filing with Susquehanna Securities, LLC (5.30%)
587,2145.30%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MEDValueChange% of portfolio
Renaissance Technologies LLC778,6106.96%$8.26M+4,9000.01%
Steamboat Capital Partners, LLC706,6996.32%$7.50M−8911.60%
Two Sigma Investments, LP481,3814.30%$5.11M+143,2230.00%
Vanguard Capital Management LLC446,6143.99%$4.74M+2,1470.00%
Charles Schwab Investment Management Inc396,9963.55%$4.21M−234,5430.00%
BlackRock, Inc.369,5033.30%$3.92M−574,9500.00%
Dimensional Fund Advisors LP363,3943.25%$3.86M+1,6320.00%
American Century Companies Inc318,9112.85%$3.38M+94,6310.00%
Morgan Stanley292,5082.62%$3.10M−32,8040.00%
Goldman Sachs Group Inc243,0852.17%$2.58M+89,9140.00%
Marshall Wace, Llp241,6492.16%$2.56MNew0.00%
Aqr Capital Management LLC236,4342.11%$2.51M+90,8590.00%
Peapod Lane Capital LLC222,5761.99%$2.36M+3,5131.59%
Lido Advisors, LLC220,3371.97%$2.34M+37,3020.01%
Trexquant Investment LP212,6841.90%$2.26M+32,6030.01%
Jane Street Group, LLC164,8811.47%$1.75M+38,4740.00%
Commons Capital, LLC149,9161.34%$1.59M+111,9161.11%
Quinn Opportunity Partners LLC127,1121.14%$1.35M–0.06%
Geode Capital Management, LLC121,0711.08%$1.29M−132,2440.00%
Bridgeway Capital Management, LLC117,0781.05%$1.24M−40,0000.02%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20261138M73.9%26 / 4328 / 242M2M
Q1 20261129M76.9%26 / 3333 / 202M1M
Q4 20251098M72.3%14 / 2448 / 271M2M
Q3 20251239M83.1%20 / 4325 / 171M1M
Q2 20251209M77.3%23 / 4530 / 271M1M
Q1 20251248M73.7%21 / 3741 / 241M2M
Q4 20241299M79.8%19 / 3546 / 301M1M
Q3 20241409M82.5%23 / 2954 / 392M2M
Q2 202415810M93.5%38 / 5146 / 654M6M
Q1 202418612M100.0%25 / 6166 / 553M2M
Q4 202321611M95.7%33 / 7672 / 392M1M
Q3 20232239M84.9%29 / 7284 / 421M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

137 funds held MED in Q1 2026, 63% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MEDValue% of fundAs of
Schwab Fundamental U.S. Small Company ETF377,6163.38%$4.73M0.05%May 31, 2026
Vanguard Total Stock Market Index Fund318,9802.85%$3.38M0.00%Jun 30, 2026
Avantis U.S. Small Cap Value ETF232,3662.08%$2.91M0.01%May 31, 2026
Vanguard Consumer Staples Index Fund130,6681.17%$1.64M0.02%May 31, 2026
iShares U.S. Small-Cap Equity Factor ETF120,9731.08%$1.19M0.03%Jul 31, 2026
Vanguard Extended Market Index Fund115,5431.03%$1.23M0.00%Jun 30, 2026
U.S. Small Cap Value Portfolio110,8080.99%$1.09M0.01%Jul 31, 2026
Schwab Fundamental U.S. Small Company Index Fund67,4820.60%$663.35K0.03%Jul 31, 2026
Fidelity Extended Market Index Fund66,4630.59%$832.78K0.00%May 31, 2026
Dimensional US Small Cap Value ETF60,6230.54%$595.92K0.01%Jul 31, 2026
Vanguard Russell 2000 Index Fund55,5680.50%$696.27K0.00%May 31, 2026
Schwab U.S. Small-Cap ETF50,9350.46%$638.22K0.00%May 31, 2026
EA Bridgeway Omni Small-Cap Value ETF48,9120.44%$518.96K0.02%Jun 30, 2026
U.S. Small Cap Portfolio44,3600.40%$436.06K0.00%Jul 31, 2026
Ultra-Small Company Fund40,9000.37%$433.95K0.44%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Nicholas Mark JohnsonPresident13,4570.12%Mar 27, 2026
Jonathan Barrett MacKenzieVP, Finance & CAO20,8380.19%Mar 27, 2026
James P. MaloneyChief Financial Officer37,6750.34%Mar 27, 2026
Parsa KiaiDirector32,7690.29%Nov 6, 2026
Daniel R. ChardDirector336,5203.01%Sep 30, 2026
Jeffrey Matthew RoseDirector11,6800.10%May 28, 2026
Scott SchlackmanDirector42,2290.38%May 28, 2026
Ming XianDirector––May 28, 2026
Andrea B. ThomasDirector35,6970.32%May 28, 2026
Elizabeth A. GearyDirector31,2250.28%May 28, 2026
Michael A. HoerDirector26,1390.23%Jun 26, 2025
Jeffrey J. BrownDirector33,3610.30%Jun 26, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Parsa Kiai
Director
Nov 4, 2026Buy+661$13.03$8.61K21,089
Parsa Kiai
Director
Oct 28, 2026Buy+158$12.24$1.93K20,428
Parsa Kiai
Director
Oct 28, 2026Buy+5,399$12.24$66.09K712,891
Daniel R. Chard
Director
Sep 29, 2026Sale(10b5-1 plan)−9,544$11.73$111.95K130,609
Daniel R. Chard
Director
Sep 28, 2026Sale(10b5-1 plan)−9,545$11.98$114.35K140,153
Parsa Kiai
Director
Aug 26, 2026Buy+1,175$12.26$14.41K20,270
Parsa Kiai
Director
Aug 26, 2026Buy+41,975$12.26$514.61K707,492
Parsa Kiai
Director
Aug 24, 2026Buy+118$12.00$1.42K19,095
Parsa Kiai
Director
Aug 24, 2026Buy+4,211$12.00$50.53K665,517
Parsa Kiai
Director
Aug 20, 2026Buy+1,175$11.60$13.63K18,977
Parsa Kiai
Director
Aug 20, 2026Buy+41,975$11.60$486.91K661,306
Parsa Kiai
Director
Aug 19, 2026Buy+28,538$11.66$332.75K619,331
Parsa Kiai
Director
Aug 19, 2026Buy+799$11.66$9.32K17,802
Parsa Kiai
Director
May 26, 2026Award+11,680––11,680
Parsa Kiai
Director
May 26, 2026Award+7,637––19,317
Jeffrey Matthew Rose
Director
May 26, 2026Award+11,680––11,680
Jeffrey Matthew Rose
Director
May 26, 2026Award+6,739––18,419
Elizabeth A. Geary
Director
May 26, 2026Award+11,680––31,225
Scott Schlackman
Director
May 26, 2026Award+11,680––42,229
Andrea B. Thomas
Director
May 26, 2026Award+11,680––35,697
Scott Schlackman
Director
May 11, 2026Buy+2,500$12.53$31.33K30,549
Scott Schlackman
Director
May 8, 2026Buy+2,500$12.65$31.63K28,049
Daniel R. Chard
Chairman & CEO, Director
Mar 25, 2026Tax withholding−20,095$9.59$192.71K146,438
Daniel R. Chard
Chairman & CEO, Director
Mar 25, 2026Award+36,968––183,406
Daniel R. Chard
Chairman & CEO, Director
Mar 25, 2026Award+4,827––188,233
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 25, 2026Award+10,830––20,838
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 25, 2026Tax withholding−862$9.59$8.27K10,008
James P. Maloney
Chief Financial Officer
Mar 25, 2026Tax withholding−3,224$9.59$30.92K37,675
James P. Maloney
Chief Financial Officer
Mar 25, 2026Award+34,344––72,019
James P. Maloney
Chief Financial Officer
Mar 25, 2026Award+1,014––73,033
Daniel R. Chard
Chairman & CEO, Director
Mar 20, 2026Buy+17,678$10.11$178.72K17,678
Daniel R. Chard
Chairman & CEO, Director
Mar 17, 2026Tax withholding−2,638$10.05$26.51K166,533
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 17, 2026Tax withholding−70$10.05$70410,870
James P. Maloney
Chief Financial Officer
Mar 17, 2026Tax withholding−482$10.05$4.84K40,899
Daniel R. Chard
Chairman & CEO, Director
Mar 13, 2026Tax withholding−7,075$9.62$68.06K169,171
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 13, 2026Tax withholding−198$9.62$1.90K10,940
James P. Maloney
Chief Financial Officer
Mar 13, 2026Tax withholding−918$9.62$8.83K41,381
Jeffrey J. Brown
Director
Jun 25, 2025Award+11,167.54––29,128
Jeffrey J. Brown
Director
Jun 25, 2025Award+9,449.46$13.39$126.53K38,578
Michael A. Hoer
Director
Jun 25, 2025Award+11,168––26,139
Elizabeth A. Geary
Director
Jun 25, 2025Award+11,168––19,545
Andrea B. Thomas
Director
Jun 25, 2025Award+11,168––24,017
Scott Schlackman
Director
Jun 25, 2025Award+11,168––25,549
Daniel R. Chard
Chairman & CEO, Director
Jun 13, 2025Buy+381$13.13$5.00K149,698
James P. Maloney
Chief Financial Officer
Mar 25, 2025Award+24,161––42,299
Daniel R. Chard
Chairman & CEO, Director
Mar 25, 2025Award+124,953––176,246
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 25, 2025Award+7,671––11,138
James P. Maloney
Chief Financial Officer
Mar 17, 2025Tax withholding−438$14.35$6.29K18,138
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 17, 2025Tax withholding−99$14.35$1.42K3,467
Daniel R. Chard
Chairman & CEO, Director
Mar 17, 2025Tax withholding−1,864$14.35$26.75K51,293
James P. Maloney
Chief Financial Officer
Mar 16, 2025Tax withholding−123$13.94$1.71K18,576
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 16, 2025Tax withholding−60$13.94$8363,566
Daniel R. Chard
Chairman & CEO, Director
Mar 16, 2025Tax withholding−944$13.94$13.16K53,157
James P. Maloney
Chief Financial Officer
Mar 13, 2025Tax withholding−835$13.87$11.58K18,699
Jonathan Barrett MacKenzie
VP, Finance & CAO
Mar 13, 2025Tax withholding−280$13.87$3.88K3,626
Daniel R. Chard
Chairman & CEO, Director
Mar 13, 2025Tax withholding−5,001$13.87$69.36K54,101
Daniel R. Chard
Chairman & CEO, Director
Dec 3, 2024Gift−149,317.35––0
Daniel R. Chard
Chairman & CEO, Director
Dec 3, 2024Gift+149,317.35––149,317
Jonathan Barrett MacKenzie
VP, Finance & CAO
Sep 13, 2024Tax withholding−11$18.90$2083,906
Andrea B. Thomas
Director
Jun 20, 2024Award+6,596––12,849

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
13.23%
1M shares short
Days to cover
8.2
At 0M shares a day
Change since last report
+12.1%
From 1M shares
Short volume, 20 days
46.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Medifast's stock actually held short. Settlement fails (shares not delivered on time) peaked at 883,414 shares on Sep 21, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Daniel R. Chard
Officer
Sep 29, 20269,544$111.95KSep 29, 2026Stock Award
Daniel R. Chard
Officer
Sep 28, 20269,545$114.34KSep 28, 2026Stock Award
Scott Schlackman
Director
Mar 8, 20244,053$159.87KMar 8, 2024Restricted Stock
Jeffrey J. Brown
Director
Aug 14, 202338,316$3.60MAug 14, 2023Dividend Reinvestment

Congress trades

2 trades in Medifast reported by 1 member of the House

MemberTypeTradedAmountFiled
Donna Shalala
FL27
SoldJun 24, 2019$1K–15KApr 27, 2020
308 days late
Donna Shalala
FL27
BoughtApr 30, 2019$1K–15KApr 27, 2020
363 days late

See a number that looks wrong?